Immune targets and neoantigens for cancer immunotherapy and precision medicine
27
This work was supported,in part,by grants from the NCI and NIDA,NIH R01CA101795,R01DA030338 and U54CA210181,Cancer Prevention and Research Institute of Texas CPRIT;DP150099,RP150611 and RP170537,Department of Defense DoD CDMRP BCRP BC151081,and Golfer against cancer foundation.
2017-02-27(万方平台首次上网日期,不代表论文的发表时间)
11-37